Funded biopharmaceutical research projects that have been completed
To date, CQDM has launched 86 calls for proposals, evaluated 1100 research projects and implemented 18 funding biopharmaceutical research funding programs. Information on our current programs.
The following outlines the biopharmaceutical research funding programs that have been completed to date: CQDM-CIHR, Explore, Focus, Focus on Brain, Canada/Germany, Quebec/Massachusetts, Quebec/Ontario.
Details on key facts and numbers on CQDM’s impact.
|
Key objectives |
Innovative advanced technologies, IT tools and medical devices that will facilitate research and development in the field of personalized medicine |
|
Scope and research agenda |
Large-scale projects that generate applicable results in biopharmaceutical research related to cancer, infection and immunity and neurodegeneration affecting cognition. |
|
Targeted regions |
Canada |
|
Eligibility |
Academic or hospital laboratories as well as SMEs (biotech companies and contract research companies) and NPOs |
|
Public/private partnership |
Required |
|
Project specifics of the completed biopharmaceutical research funding programs |
|
|
Selection criteria |
Strong and immediate impact on the drug discovery or development process and active involvement of the private partners. |
|
Project duration |
Up to 30 months |
|
Maximum amount |
$750,000 |
|
List of projects |
To date, 2 projects are underway or completed. |
Information on completed biopharmaceutical research funding programs.
|
Key objectives |
Innovative technologies, tools and platforms that accelerate or facilitate the drug discovery/development process |
|
Scope and research agenda |
Preliminary validation of innovative and forward-thinking ideas that could lead to revolutionary technologies |
|
Targeted regions |
Quebec and Ontario |
|
Eligibility |
Academic laboratories and SMEs (biotech companies and contract research companies). |
|
Public/private partnership |
Not required |
|
Project specifics of the completed biopharmaceutical research funding programs |
|
|
Selection criteria |
Potential disruptive impact, uniqueness and innovation. |
|
Project duration |
Maximum 2 years |
|
Maximum amount |
$300,000 |
|
List of projects |
To date, 21 projects are underway or completed. |
|
Key objectives |
Innovative technologies, tools and platforms to accelerate or facilitate the discovery or development of drugs in several therapeutic areas. |
|
Scope and research agenda |
Large-scale projects that generate applicable results to biopharmaceutical research. |
|
Targeted regions |
Quebec |
|
Eligibility |
Academic laboratories, NPOs and SMEs (biotech companies and contract research companies). |
|
Public/private partnership |
Encouraged |
|
Project specifics of the completed biopharmaceutical research funding programs |
|
|
Selection criteria |
Scientific excellence, creativity and innovative nature, feasibility of execution, potential of application, history of the team. |
|
Project duration |
Maximum 3 years |
|
Maximum amount |
$2,000,000 |
|
List of projects |
To date, 12 projects are underway or completed. |
Information on completed biopharmaceutical research funding programs.
|
Key objectives |
Innovative technologies, tools and platforms that accelerate or facilitate the drug discovery/development process in neurosciences. |
|
Scope and research agenda |
Large-scale projects that generate applicable results to neuroscience biopharmaceutical research. |
|
Targeted regions |
Minimum of two Canadian provinces |
|
Eligibility |
Academic laboratories and SMEs (biotech companies and contract research companies). |
|
Public/private partnership |
Encouraged |
|
Project specifics of the completed biopharmaceutical research funding programs |
|
|
Selection criteria |
Scientific excellence, feasibility and efficiency, strategic positioning, business opportunities and added value. |
|
Project duration |
Maximum 3 years |
|
Maximum amount |
$1,500,000 |
|
List of projects |
To date, 8 projects are underway or completed. |
Information on completed biopharmaceutical research funding programs.
|
Key objectives |
Innovative technologies, tools and platforms that accelerate or facilitate the drug discovery/development process. |
|
Scope and research agenda |
Large-scale projects that generate applicable results to biopharmaceutical research. |
|
Targeted regions |
Canada and Germany |
|
Eligibility |
Academic laboratories and SMEs (biotech companies and contract research companies). Pharmaceutical companies (multinationals) are not eligible. |
|
Public/private partnership |
Encouraged |
|
Project specifics of the completed biopharmaceutical research funding programs |
|
|
Selection criteria |
Public / private collaboration, generating clear deliverables and innovative nature. |
|
Project duration |
Minimum 2 years, maximum 3 years |
|
Maximum amount |
$1,000,000 |
|
List of projects |
As of today, 1 project is ongoing or completed. |
Information on completed biopharmaceutical research funding programs.
|
Key objectives |
State-of-the-art products or processes for life science marketing. |
|
Scope and research agenda |
Collaborative projects from competitive or precompetitive fields. |
|
Targeted regions |
Quebec and Massachusetts |
|
Eligibility |
SME |
|
Public/private partnership |
Not required |
|
Project specifics of the completed biopharmaceutical research funding programs |
|
|
Innovative and collaborative nature, potential for application and commercialization. |
Public / private collaboration, generating clear deliverables and innovative nature. |
|
Project duration |
Maximum 2 years |
|
Maximum amount |
Maximum df $500,000 for the Quebec share, matched 1:1 by the Quebec company. |
|
List of projects |
To date, 1 project is underway or completed. |
Information on completed biopharmaceutical research funding programs.
|
Key objectives |
Innovative technologies, tools and platforms that accelerate or facilitate the drug discovery/development process. |
|
Scope and research agenda |
Large-scale projects that generate applicable results for biopharmaceutical health research. |
|
Targeted regions |
Quebec and Ontario |
|
Eligibility |
Educational institutions and SMEs that plan to commercialize innovations in the region. |
|
Public/private partnership |
Encouraged |
|
Project specifics of the completed biopharmaceutical research funding programs |
|
|
Scientific excellence, creativity and innovative nature, feasibility of execution, potential of application, history of the team. |
Public / private collaboration, generating clear deliverables and innovative nature. |
|
Project duration |
Maximum 3 years |
|
Maximum amount |
$900,000 |
|
List of projects |
To date, 5 projects are underway or completed. |
